应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
LD iPath Bloomberg Lead Subindex Total Return ETN
停牌 06-07 16:00:00 EDT
44.95
+0.00
0.00%
最高
44.95
最低
44.95
成交量
0.00
今开
44.95
昨收
44.95
日振幅
0.00%
总市值
121.59万
流通市值
121.59万
总股本
2.70万
成交额
902.14
换手率
0.00%
流通股本
2.70万
市净率
--
ROE
--
每股收益
0.00
52周最高
51.00
52周最低
36.20
市盈率
--
股息
0.00
股息收益率
0.00
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
创响生物与Ikena Oncology合并，融资7500万美元 ，OX40 单克隆抗体能否撑起未来？
市场资讯 · 2024-12-25
创响生物与Ikena Oncology合并，融资7500万美元 ，OX40 单克隆抗体能否撑起未来？
起底艾伯维神经科学领域
艾美达医药咨询 · 2024-10-21
起底艾伯维神经科学领域
【Helix Labs完成200万美元Pre-Seed轮融资，Tribe Capital等领投】金色财经报道，Helix
金色财经 · 2024-09-23
【Helix Labs完成200万美元Pre-Seed轮融资，Tribe Capital等领投】金色财经报道，Helix
加载更多
公司概况
公司名称：
iPath Bloomberg Lead Subindex Total Return ETN
所属市场：
ARCA
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"LD","market":"US","secType":"STK","nameCN":"iPath Bloomberg Lead Subindex Total Return ETN","latestPrice":44.95,"timestamp":1686168000000,"preClose":44.95,"halted":3,"volume":0,"delay":0,"floatShares":27049,"shares":27049,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"06-07 16:00:00 EDT","open":44.95,"high":44.95,"low":44.95,"amount":902.14,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":44.95,"sharesOutstanding":27049,"nav":44.6497,"aum":0,"bidAskSpread":0.058525,"volumeRatio":0},"requestUrl":"/m/hq/s/LD","defaultTab":"news","newsList":[{"id":"2494018455","title":"创响生物与Ikena Oncology合并，融资7500万美元 ，OX40 单克隆抗体能否撑起未来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2494018455","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494018455?lang=zh_cn&edition=full","pubTime":"2024-12-25 14:01","pubTimestamp":1735106460,"startTime":"0","endTime":"0","summary":"合并后的公司将专注于开发针对OX40的单克隆抗体IMG-007，用于治疗特应性皮炎。IMG-007是一种具有Fc调节功能并沉默ADCC的OX40抗体，旨在最小化潜在的安全风险。结论单次剂量高达600 mg的IMG-007在健康参与者中耐受良好，并在高剂量下表现出延长的半衰期。IMG-007，作为一种非消耗性抗 OX40 单克隆抗体，通过抗体工程设计延长了半衰期，同时沉默了ADCC功能，与协和麒麟的Rocatinlimab设计正好相反。从疗效方面，也是OX40L抗体amlitelimab更优。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225145326a208a5e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225145326a208a5e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4138","CVR","AE","PK","BK4539","IKNA","BK4181","BK4218","BK4161","LD"],"gpt_icon":0},{"id":"2477881865","title":"起底艾伯维神经科学领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2477881865","media":"艾美达医药咨询","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477881865?lang=zh_cn&edition=full","pubTime":"2024-10-21 15:00","pubTimestamp":1729494044,"startTime":"0","endTime":"0","summary":"2023年12月，艾伯维又斥资87亿美元收购神经科学制药Cerevel Therapeutics，拿下多款具有BIC潜力的管线，进一步巩固了艾伯维在神经科学领域的领先地位。艾伯维神经科学板块的部分产品及在研管线，图源：凯莱英药闻目前在神经科学领域，艾伯维的上市主要产品包括3款偏头痛药物Botox、Ubrelvy、Qulipta，精神分裂症药物Vraylar，以及帕金森病药物Duodopa。或许有一天，神经科学领域的产品也能超越自免产品，成为艾伯维的新王。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410211506199f531252&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410211506199f531252&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0820561818.USD","IE00BJJMRZ35.SGD","IE00BVYPNV92.GBP","IE0009355771.USD","LU0795875086.SGD","LU0689472784.USD","PD","LU0310800379.SGD","IE00BVYPNW00.USD","LD","LU1003077747.HKD","IE00BDGV0183.EUR","LU0211327993.USD","LU0170899867.USD","LU0795875169.SGD","LU0198837287.USD","LU0456855351.SGD","LU0029864427.USD","LU0943347566.SGD","LU0553294199.USD","LU0965509010.AUD","LU0949170772.SGD","BK4139","LU1169590202.USD","IE00BFTCPJ56.SGD","LU0211328371.USD","IE00BSNM7G36.USD","LU0310799852.SGD","LU0965508806.USD","LU0256863902.USD","LU0861579265.USD","LU0256863811.USD","LU0708994859.HKD","BK4559","LU0985320562.USD","BK4550","IE00B2B36J28.USD","LU0114720955.EUR","BK4566","BK4581","ABBV","LU0203345920.USD","IE0002141913.USD","LU0882574055.USD","BK4585","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0234570918.USD","BK4023"],"gpt_icon":0},{"id":"2469195831","title":"【Helix Labs完成200万美元Pre-Seed轮融资，Tribe Capital等领投】金色财经报道，Helix","url":"https://stock-news.laohu8.com/highlight/detail?id=2469195831","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469195831?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:05","pubTimestamp":1727096736,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["03046","BK4594","CETH","ETHA","ETHV","EZET","ETH.USD.CC","09009","BK4585","ETH","IBIT","BK4588","ETHE","LDO.USD.HKCC","QETH","ETH.USD.HKCC","03009","LD","ETHW","OP.USD.HKCC","03179","09046","09179","FETH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ipathetn.com/US/16/en/details.app?instrumentId=31027","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":-0.005425},{"month":2,"riseRate":0.533333,"avgChangeRate":0.03669},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.035497},{"month":4,"riseRate":0.5,"avgChangeRate":-0.005108},{"month":5,"riseRate":0.466667,"avgChangeRate":-0.002286},{"month":6,"riseRate":0.4,"avgChangeRate":0.003045},{"month":7,"riseRate":0.866667,"avgChangeRate":0.055036},{"month":8,"riseRate":0.2,"avgChangeRate":-0.012482},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.014209},{"month":10,"riseRate":0.533333,"avgChangeRate":0.023485},{"month":11,"riseRate":0.466667,"avgChangeRate":-0.015233},{"month":12,"riseRate":0.6,"avgChangeRate":0.015362}],"exchange":"ARCA","name":"iPath Bloomberg Lead Subindex Total Return ETN","nameEN":"iPath Bloomberg Lead Subindex Total Return ETN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iPath Bloomberg Lead Subindex Total Return ETN(LD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iPath Bloomberg Lead Subindex Total Return ETN(LD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iPath Bloomberg Lead Subindex Total Return ETN,LD,iPath Bloomberg Lead Subindex Total Return ETN股票,iPath Bloomberg Lead Subindex Total Return ETN股票老虎,iPath Bloomberg Lead Subindex Total Return ETN股票老虎国际,iPath Bloomberg Lead Subindex Total Return ETN行情,iPath Bloomberg Lead Subindex Total Return ETN股票行情,iPath Bloomberg Lead Subindex Total Return ETN股价,iPath Bloomberg Lead Subindex Total Return ETN股市,iPath Bloomberg Lead Subindex Total Return ETN股票价格,iPath Bloomberg Lead Subindex Total Return ETN股票交易,iPath Bloomberg Lead Subindex Total Return ETN股票购买,iPath Bloomberg Lead Subindex Total Return ETN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iPath Bloomberg Lead Subindex Total Return ETN(LD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iPath Bloomberg Lead Subindex Total Return ETN(LD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}